Mehta, PA., Gerbing, R.B., Alonzo, T.A., Elliott, J.S., Zamzow, T.A., Combs, M., Stover, E., Ross, J.A., Perentesis, J.P., Meschinchi, S., Lange, B.J. and Davies, S.M. (2008) FAS Promoter Polymorphism: Outcome of Childhood Acute Myeloid Leukemia. A Children’s Oncology Group Report. Clinical Cancer Research, 14, 7896-7899.

has been cited by the following article:

• TITLE: Screening of Single Nucleotide Polymorphism in CD95 (APO-1/FAS) Promoter Region (G-1377A) in Children with Acute Leukemia

  AUTHORS: Dilara Fatma Akin Bali, Didem Torun Ozkan, Ahmet Emin Kurekçi, Nejat Akar

  KEYWORDS: Acute Lymphoblastic Leukemia, Acute Myeloblastic Leukemia, CD 95 Polymorphism

  JOURNAL NAME: Open Access Library Journal, Vol.5 No.3, March 9, 2018

  ABSTRACT: CD95 is a cell surface receptor involved in apoptotic signal transmission. Deregulation of this pathway results in down regulation of apoptosis and subsequent persistence of a malignant clone. A single nucleotide polymorphism (SNP) resulting in guanine-to-adenine (G > A) transition in the CD95 promoter region (position ﹣1377) is thought to reduce stimulatory protein 1 (SP1) transcription factor binding and decrease CD95 expression. The purpose of this study was to examine a genetic polymorphism in the core promoter of CD95 is associated with the frequency. G-1377A in the CD95 promoter region was genotyped by polymerase chain reaction and restriction endonuclease analysis and sequenced of the CD95 gene (Beckman Coulter, USA). Among 146 patients, CD95 G-1377A (rs2234767) SNP carriers frequencies has been identified as 25% GA (n:37) and AA 4% (n:6), respectively. This polymorphism of the distribution of the CD95 gene in acute leukemic children will be a guide for future studies.